Matthew J. Oborski

发表

A practical, time-efficient, cost-effective protocol for obtaining dynamic PET scan data in the routine clinical setting

Michael Czachowski, Charles M. Laymon, Alexandria Zahner, 2014 .

Multisite Technical and Clinical Performance Evaluation of Quantitative Imaging Biomarkers from 3D FDG PET Segmentations of Head and Neck Cancer Images

Robert J. Gillies, Ghassan Hamarneh, Payam Ahmadvand, 2020, Tomography.

Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge.

Ron Kikinis, Xia Li, Andriy Fedorov, 2014, Translational oncology.

The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge

Thomas E. Yankeelov, Guido H. Jajamovich, Xia Li, 2016, Tomography.

Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis.

Fernando E Boada, Matthew J. Oborski, Charles M Laymon, 2012, Magnetic resonance imaging.

Variations of Dynamic Contrast-Enhanced Magnetic ResonanceImaginginEvaluation

Matthew J. Oborski, Paul Kinahan, R. Kikinis, 2014 .

Image-Based 2D Re-Projection for Attenuation Substitution in PET Neuroimaging

Matthew J. Oborski, D. Minhas, J. Mountz, 2018, Molecular Imaging and Biology.

The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II

Matthew J. Oborski, F. O’Sullivan, Paul Kinahan, 2019, Tomography.

[18F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment

Matthew J. Oborski, F. Lieberman, J. Mountz, 2016, Tomography.

Improved Benefit of SPECT/CT Compared to SPECT Alone for the Accurate Localization of Endocrine and Neuroendocrine Tumors

Matthew J. Oborski, J. Mountz, G. Bural, 2012, Molecular imaging and radionuclide therapy.

Phase I study of intravenous PI3K inhibitor BAY 80-6946: Activity in patients (pts) with advanced solid tumors and non-Hodgkin lymphoma treated in MTD expansion cohorts.

Matthew J. Oborski, F. Toledo, J. Mountz, 2012 .

First use of 18F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy

Matthew J. Oborski, F. Lieberman, J. Mountz, 2014, Brain and behavior.

Challenges and Approaches to Quantitative Therapy Response Assessment in Glioblastoma Multiforme Using the Novel Apoptosis Positron Emission Tomography Tracer F-18 ML-10.

Matthew J. Oborski, F. Lieberman, J. Mountz, 2014, Translational oncology.

Cancer Management and Research Dovepress Malignant Gliomas: Current Perspectives in Diagnosis, Treatment, and Early Response Assessment Using Advanced Quantitative Imaging Methods

Matthew J. Oborski, Rafay Ahmed, James M Mountz, 2022 .

Brain imaging: assessing therapy responses using quantitative imaging biomarkers

Matthew J. Oborski, J. Mountz, C. Laymon, 2014 .

Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling.

Xia Li, Ron Kikinis, Wei Huang, 2014, Translational oncology.

The Halo Occupation Distribution of Black Holes: Dependence on Mass

Matthew J. Oborski, Zheng Zheng, D. Nagai, 2011, 1102.1437.

Multi‐site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data

Ghassan Hamarneh, Payam Ahmadvand, Sadek Nehmeh, 2017, Medical physics.

Quantifying Metabolic Heterogeneity in Head and Neck Tumors in Real Time: 2-DG Uptake Is Highest in Hypoxic Tumor Regions

Charles Laymon, James M. Mountz, Matthew J. Oborski, 2014, PloS one.

Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET.

Matthew J. Oborski, F. Lieberman, J. Mountz, 2013, Clinical nuclear medicine.

Malignant gliomas : current perspectives in diagnosis , treatment , and early response assessment using advanced quantitative imaging methods

Matthew J. Oborski, F. Lieberman, J. Mountz, 2014 .

Phase I Study of Intravenous PI3K Inhibitor Bay 80–6946: Preliminary Activity in Patients with Relapsed Non-Hodgkin Lymphoma (NHL) Treated in an MTD Expansion Cohort

Matthew J. Oborski, F. Toledo, J. Mountz, 2012 .

Informatics methods to enable sharing of quantitative imaging research data.

Fernando Boada, Andre Dekker, Charles Laymon, 2012, Magnetic resonance imaging.

Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis.

Matthew J. Oborski, F. Lieberman, J. Mountz, 2012, Magnetic resonance imaging.

Informatics methods to enable sharing of quantitative imaging research data.

Matthew J. Oborski, J. Mountz, F. Fennessy, 2012, Magnetic resonance imaging.

Cancer Management and Research Dovepress Malignant Gliomas: Current Perspectives in Diagnosis, Treatment, and Early Response Assessment Using Advanced Quantitative Imaging Methods

Matthew J. Oborski, F. Lieberman, J. Mountz, 2022 .